A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

PHASE3RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Cytomegalovirus (CMV)
Interventions
DRUG

Maribavir

Maribavir tablets

Trial Locations (12)

100044

RECRUITING

Peking University People's Hospital, Beijing

215006

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

230001

RECRUITING

Anhui Provincial Hospital(The First Affiliated Hospital of USTC), Hefei

300020

RECRUITING

Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin

310003

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

310052

RECRUITING

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

400037

RECRUITING

Xinqiao Hospital Army Medical University, Chongqing

430022

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

450004

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

510180

RECRUITING

Guangzhou First People's Hospital, Guangzhou

510515

RECRUITING

Nanfang Hospital Southern Medical University, Guangzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY